Novo Nordisk A/S
NVO
$65.77
$0.921.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.82% | 20.61% | 27.14% | 37.16% | 51.42% |
| Total Depreciation and Amortization | 20.69% | 6.53% | 9.58% | 25.14% | 21.73% |
| Total Amortization of Deferred Charges | 18.52% | 18.52% | 14.80% | 14.80% | 14.80% |
| Total Other Non-Cash Items | 299.12% | -18.67% | 42.35% | -59.16% | -72.51% |
| Change in Net Operating Assets | -52.13% | 1.59% | -733.55% | 101.58% | 23.83% |
| Cash from Operations | 39.31% | 11.11% | 11.55% | 31.45% | 13.66% |
| Capital Expenditure | -74.13% | -82.46% | -91.96% | -86.66% | -100.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 90.08% | 90.08% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -51.64% | 101.63% | 22.54% | -12.73% | 47.20% |
| Cash from Investing | -314.30% | -190.78% | -23.89% | -32.43% | -17.08% |
| Total Debt Issued | -- | -- | 36,354.74% | 52,996.92% | -- |
| Total Debt Repaid | -1,282.08% | -331.83% | -368.34% | -335.35% | -4.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 32.03% | 32.56% | 18.96% | -0.02% | -11.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.84% | -40.21% | -40.21% | -55.16% | -55.16% |
| Other Financing Activities | 1,008.73% | -- | -- | -- | 194.97% |
| Cash from Financing | 157.07% | 112.20% | 36.00% | 26.10% | -34.01% |
| Foreign Exchange rate Adjustments | 62.40% | 485.36% | 32.55% | 141.94% | 144.37% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 482.86% | -12.51% | 841.37% | 4,664.26% | -511.65% |